Cyclophosphamide Capsule
Product Images NDC 69097-517

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Cyclophosphamide (NDC 69097-517). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cipla Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

F57dbebf F145 4e3c Bfef B7907f6e01eb 01

Chemical structure of Cyclophosphamide monohydrate, showing a phosphoramide mustard derivative with an oxazaphosphorine ring and two chloroethylamine side chains, including a water molecule (H2O).*

FDA Label Image

F57dbebf F145 4e3c Bfef B7907f6e01eb 02

Label for Cyclophosphamide Capsules 25 mg by Cipla USA Inc. The label identifies the product as a cytotoxic agent and provides warnings to wear gloves when handling. It specifies a package size of 100 capsules, includes storage and handling instructions, and notes manufacturing by Cipla Ltd., India. The label features barcode and serial number details, with revision dated 1/2020.*

FDA Label Image

F57dbebf F145 4e3c Bfef B7907f6e01eb 03

Cyclophosphamide 50 mg capsules label showing the product as a cytotoxic agent. The label indicates 100 capsules per container, manufactured by Cipla Ltd. and marketed by Cipla USA Inc. It includes handling precautions, storage conditions, and a barcode on the right side.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.